Physician

Kurt Thomas Scavelli, M.D.

According to 2025 Medicare claims, Kurt Scavelli, M.D. (NPI: 1427408228) practices ophthalmology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is RETINA ASSOCIATES, PLLC (NPI: 1760408397; TIN: 562043271) and primary practice location at 27834-3796.

Scavelli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 742 traditional Medicare patients, billed 13,338 HCPCS/CPT codes, and received $1,540,395 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 426 prescription claims across 149 beneficiaries totaling $15,425 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 14 records totaling $554. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,244 to $1,540,395. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,505 to $15,425. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$770K$1.5M2020 Medicare payment: $4,244 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $9,670 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $295,274 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,171,045 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,540,395 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20203233$4,244
20217076$9,670
20223031,773$295,274
20236618,690$1,171,045
202474213,338$1,540,395

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$8.5K$17K2017 Drug cost: $1,505 (USD; Tot_Drug_Cst)2018 Drug cost: $5,028 (USD; Tot_Drug_Cst)2019 Drug cost: $7,915 (USD; Tot_Drug_Cst)2020 Drug cost: $9,098 (USD; Tot_Drug_Cst)2021 Drug cost: $10,044 (USD; Tot_Drug_Cst)2022 Drug cost: $17,046 (USD; Tot_Drug_Cst)2023 Drug cost: $11,543 (USD; Tot_Drug_Cst)2024 Drug cost: $15,425 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20172537$1,505
20184483$5,028
201977159$7,915
202079171$9,098
202182156$10,044
202282213$17,046
2023111272$11,543
2024149426$15,425

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye279865$93
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more251251$77
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more326496$64
92134Imaging of retina338789$29
92250Photography of the retina579748$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1124,043$5,242
DifluprednateDifluprednate11180$1,493
Ketorolac TromethamineKetorolac Tromethamine562,037$1,259
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat584,270$1,159
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha46621$488

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$554Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kurt Thomas Scavelli, M.D.?

Tedicare shows public-source Medicare data for Kurt Thomas Scavelli, M.D. (NPI 1427408228), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kurt Thomas Scavelli, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kurt Thomas Scavelli, M.D.?

Kurt Thomas Scavelli, M.D. is linked to RETINA ASSOCIATES, PLLC (billing NPI 1760408397) in the available physician profile data.

Does Kurt Thomas Scavelli, M.D. have Open Payments data?

Kurt Thomas Scavelli, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.